postpartum%20depression
POSTPARTUM DEPRESSION

Postpartum depression is the occurrence of a major depressive episode within 4 weeks following delivery or up to a year after childbirth.

It may peak at 2-4 weeks and 10-14 weeks after childbirth.

Symptoms are similar to that of major depression but with additional features distinctive of the postpartum period like feelings of being overwhelmed and inadequate as a parent.

Postpartum Depression References

  1. BC Reproductive Mental Health Program & Perinatal Services BC. Best practice guidelines for mental health disorders in the perinatal period. BC Children’s Hospital Reproductive Mental Health. https://reproductivementalhealth.ca. Mar 2014.
  2. Coryell W. Drug treatment of depression. Merck Manual Professional Version. https://www.merckmanuals.com. May 2018.
  3. National Institute for Health and Care Excellence (NICE). Identifying and assessing mental health problems in pregnancy and the postnatal period. NICE. http://pathways.nice.org.uk. 21 Dec 2017.
  4. National Institute for Health and Care Excellence (NICE). Managing mental health problems in pregnancy and the postnatal period. NICE. https://pathways.nice.org.uk. 21 Dec 2017.
  5. National Institute for Health and Care Excellence (NICE). Pharmacological treatments for antenatal and postnatal mental health problems. NICE. https://pathways.nice.org.uk. 21 Dec 2017.
  6. National Institute for Health and Care Excellence (NICE). Treating severe mental illness in pregnancy and the postnatal period. NICE. https://pathways.nice.org.uk. 21 Dec 2017.
  7. National Institute for Health and Care Excellence (NICE). Treating specific mental health problems in pregnancy and the postnatal period. NICE. https://pathways.nice.org.uk. 21 Dec 2017.
  8. Postpartum depression. ClinicalKey. https://www.clinicalkey.com. 10 Aug 2018.
  9. Sharma V, Sharma P. Postpartum depression: diagnostic and treatment issues. J Obstet Gynaecol Can. 2012 May;34(5):436-442. doi: 10.1016/S1701-2163(16)35240-9. PMID: 22555136
  10. Stewart DE, Vigod S. Postpartum depression. N Engl J Med. 2016 Dec 1;375(22):2177-2186. doi: 10.1056/NEJMcp1607649. PMID: 27959754
  11. Tumolo J. Brexanolone may outperform SSRIs for postpartum depression. Psych Congress Network. https://www.psychcongress.com. 26 Oct 2018.
  12. Women’s Health Committee. Perinatal anxiety and depression. The Royal Australian and New Zealand College of Obstetricians and Gynaecologists. https://www.ranzcog.edu.au/. Mar 2015.
  13. FDA approves first treatment for post-partum depression. U.S. Food & Drug Administration. https://www.fda.gov. 19 Mar 2019.
  14. Zulresso prescribing information. https://www.accessdata.fda.gov. Mar 2019.
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 2 days ago
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Audrey Abella, 4 days ago
Extremes of sleep duration (≤5 or ≥10 hours/day), which is a known mortality risk factor in the general population, may increase absolute mortality in adults with type 2 diabetes (T2D), a prospective study has shown.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.